PP
EGRX

PDT Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

PDT Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,011
Closed -$112K – 867
2024
Q3 		$112K Hold
30,011
– – 0.01% 693
2024
Q2 		$168K Buy
30,011
+2,953
+11% +$12.9K 0.02% 624
2024
Q1 		$142K Buy
+27,058
New +$149K 0.01% 597
2023
Q4 		– Sell
-19,745
Closed -$311K – 699
2023
Q3 		$311K Buy
+19,745
New +$355K 0.04% 471
2020
Q1 		– Sell
-36,701
Closed -$2.21M – 890
2019
Q4 		$2.21M Sell
36,701
-17,423
-32% -$1.04M 0.14% 186
2019
Q3 		$3.06M Sell
54,124
-976
-2% -$54.9K 0.18% 155
2019
Q2 		$3.07M Sell
55,100
-14
-0% -$730 0.18% 145
2019
Q1 		$2.78M Buy
55,114
+10,803
+24% +$481K 0.16% 163
2018
Q4 		$1.78M Sell
44,311
-28,289
-39% -$1.46M 0.1% 213
2018
Q3 		$5.03M Sell
72,600
-11,391
-14% -$864K 0.21% 145
2018
Q2 		$6.36M Buy
83,991
+250
+0.3% +$15.7K 0.24% 137
2018
Q1 		$4.41M Sell
83,741
-22,096
-21% -$1.28M 0.15% 180
2017
Q4 		$5.65M Buy
+105,837
New +$5.89M 0.16% 174
2016
Q1 		– Sell
-19,200
Closed -$1.7M – 606
2015
Q4 		$1.7M Sell
19,200
-16,952
-47% -$1.34M 0.23% 159
2015
Q3 		$2.68M Buy
36,152
+9,718
+37% +$809K 0.06% 354
2015
Q2 		$2.14M Buy
26,434
+1,907
+8% +$124K 0.06% 409
2015
Q1 		$1.03M Buy
+24,527
New +$696K 0.03% 790

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

PDT Partners's EGRX Position: Q4 2024 in Review

PDT Partners sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 30,011 shares — an estimated $112K sold.

PDT Partners first reported a position in EGRX in Q1 2015 and held it in 17 quarters. The position peaked at $6.36M in Q2 2018. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • PDT Partners reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • PDT Partners sold 30,011 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $112K.
  • PDT Partners first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 17 quarters.
  • PDT Partners's Eagle Pharmaceuticals, Inc. position peaked at $6.36M in Q2 2018.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.